Immunology News and Research

Latest Immunology News and Research

GlaxoSmithKline Acquires Sirtris Pharmaceuticals

GlaxoSmithKline has announced that it has completed its acquisition of Sirtris Pharmaceuticals, Inc. (Sirtris) for approximately USD720 million (or approx. GBP362 million) through a cash tender offer and merger of USD22.50 (or approx. GBP11.33) per share.

8 Jun 2008

New grant to enable University of Rochester to increase HIV research by 25 percent

The University of Rochester today announced that the National Institutes of Health (NIH) has awarded a team of more than 50 researchers a five-year, $3.2 million grant.

4 Jun 2008

New molecular mechanism for colorectal cancer

Scientists in Portugal just found a new molecular mechanism behind colorectal cancer in which a mutated and a normal, but over-expressed, gene cooperate and are both needed to create the disease.

4 Jun 2008

Vigorous exercise helps seniors avoid disability

Healthy seniors who are physically active and exercise for more than 60 minutes each week can lessen their chances of disability as they age, finds a new long-term study.

3 Jun 2008

Probiotics provide hay fever hope

With the peak grass pollen season approaching, scientists can reveal that a daily dose of probiotic can change the immune status of people with hay fever.

2 Jun 2008

New approach to treating autoimmune disease offered by Weizmann scientists

In autoimmune diseases, the immune system turns against the body's own tissues and organs, wreaking havoc and destruction for no apparent reason. Partly because the origins of these diseases are so obscure, no effective treatment exists, and the suffering they inflict is enormous.

2 Jun 2008

Researchers find gene signature profile for metastasis

A common signature of tiny, specific pieces of non-coding genetic material known as microRNAs (miRNAs) may be directly involved in the spread of cancer to other parts of the body.

2 Jun 2008

Why some treatments rescue aging skin

Fine wrinkles, deeper creases, saggy areas around the mouth and neck - the sights in the mirror that make baby boomers wince - are not inevitable. They result from a structural breakdown inside the skin that some existing treatments effectively counteract by stimulating the growth of new, youthful collagen, University of Michigan scientists say.

28 May 2008

Allergy - it's in the genes

In a world first scientists at theWestmead Millennium Institute have identified how a gene associated with allergic diseases such as asthma and eczema works, providing new hope for potential drug treatments.

28 May 2008

New cancer vaccine protein target found

Cancer Research UK scientists have identified an important new protein target which could be used to produce highly focused vaccine therapies for cancer - according to research published in the Journal of Clinical Investigation.

25 May 2008

Yerkes researchers develop first transgenic nonhuman primate model of Huntington's disease

In the first study of its kind, researchers at the Yerkes National Primate Research Center, Emory University, in collaboration with researchers from the Department of Human Genetics at Emory's School of Medicine, have developed the first transgenic nonhuman primate model of Huntington's disease (HD), one of the most devastating human neurodegenerative diseases.

22 May 2008

New program promises to solve puzzling medical cases

A new research program in the U.S. promises to provide some answers for people suffering from mysterious diseases that have defied diagnosis.

21 May 2008

Having a cat may protect children from developing asthma

A study released by researchers at the Columbia Center for Children's Environmental Health (CCCEH) at Columbia University's Mailman School of Public Health, shows that cat ownership may have a protective effect against the development of asthma symptoms in young children at age five.

20 May 2008

Scripps Research Institute awarded patent for revolutionary technology

The Scripps Research Institute has been awarded U.S. Patent No. US 7,375,234 B2, which covers a broad class of chemical reactions that mimic biological efficiency and opens the door to a new world of chemistry.

20 May 2008

VCU research team awarded NIH grant to study asthma, allergic disease

A team of Virginia Commonwealth University researchers has received a National Institute of Allergy and Infectious Diseases grant totaling nearly $7.3 million for a Cooperative Research Center to study various aspects of asthma and allergic disease.

20 May 2008

NIAID to advance B-cell approach to HIV vaccines

To advance underdeveloped approaches to designing a preventive HIV vaccine, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is launching a new program to foster the study of B cells, immune cells that can produce antibodies with the capacity to neutralize HIV.

20 May 2008

Abnormal "editing" of gene messages may cause Lupus

Researchers at Wake Forest University have uncovered evidence that the abnormal "editing" of gene messages in a type of white blood cell may be behind the development of lupus. Scientists hope the finding will lead to earlier diagnosis, a way to monitor patients' response to therapy and possibly a new way to treat the disease.

19 May 2008

Investigational smallpox drug may treat adenovirus infections in humans

Scientists at Saint Louis University have made two key discoveries that could lead to the first-ever human testing of a drug to target the adenovirus, which causes a number of severe upper-respiratory infections and is one of many viruses that causes the common cold.

19 May 2008

NIH launches undiagnosed diseases program

The National Institutes of Health (NIH) today announced a new clinical research program that will aim to provide answers to patients with mysterious conditions that have long eluded diagnosis. Called the Undiagnosed Diseases Program, the trans-NIH initiative will focus on the most puzzling medical cases referred to the NIH Clinical Center in Bethesda, Md., by physicians across the nation.

19 May 2008

Rochester vaccine triggers immune response, prevents Alzheimer's

A vaccine created by University of Rochester Medical Center scientists prevents the development of Alzheimer's disease-like pathology in mice without causing inflammation or significant side effects.

19 May 2008